Key Takeaways
- HIPAA protects patient health information (PHI) and requires privacy safeguards.
- The FDA regulates drug safety, efficacy, manufacturing, and labeling.
- The Poison Prevention Packaging Act requires child-resistant containers for most medications.
- The Omnibus Budget Reconciliation Act (OBRA-90) mandates prospective drug utilization review.
- The Combat Methamphetamine Epidemic Act restricts pseudoephedrine sales.
Federal Regulations
Federal laws establish the foundation for pharmacy practice across all states. Understanding these regulations is essential for the ExCPT exam and for maintaining compliance in daily pharmacy operations.
HIPAA - Health Insurance Portability and Accountability Act
HIPAA (1996) is the primary federal law protecting patient health information. It established national standards for electronic healthcare transactions and privacy requirements.
HIPAA Privacy Rule
The Privacy Rule establishes standards for protecting Protected Health Information (PHI).
PHI includes:
- Patient names, addresses, phone numbers
- Medical records and prescription history
- Insurance and billing information
- Any information that can identify a patient
Key HIPAA Requirements for Pharmacies
| Requirement | Description |
|---|---|
| Minimum Necessary Standard | Only access/share the minimum PHI needed for the task |
| Notice of Privacy Practices | Provide patients with written notice of how PHI is used |
| Patient Access | Patients can request copies of their PHI |
| Business Associate Agreements | Contracts required with vendors who access PHI |
| Staff Training | All employees must receive HIPAA training |
| Physical Safeguards | Secure storage of records, private counseling areas |
HIPAA Violations and Penalties
| Violation Type | Penalty Range |
|---|---|
| Unknowing | $100 - $50,000 per violation |
| Reasonable Cause | $1,000 - $50,000 per violation |
| Willful Neglect (Corrected) | $10,000 - $50,000 per violation |
| Willful Neglect (Not Corrected) | $50,000 per violation (minimum) |
| Annual Maximum | $1.5 million per violation category |
Permitted PHI Disclosures
PHI may be disclosed without patient authorization for:
- Treatment - Sharing information with other healthcare providers
- Payment - Insurance billing and claims processing
- Healthcare Operations - Quality improvement, training
- Public Health Activities - Disease reporting, FDA reporting
- Law Enforcement - Court orders, subpoenas (with proper documentation)
Exam Tip
Remember the TPO rule: Disclosure without authorization is permitted for Treatment, Payment, and healthcare Operations.
FDA - Food and Drug Administration
The FDA regulates drugs, biologics, medical devices, and food safety. For pharmacy technicians, understanding FDA drug regulations is most relevant.
Key FDA Functions
| Function | Description |
|---|---|
| Drug Approval | Reviews new drug applications (NDAs) and abbreviated new drug applications (ANDAs) for generics |
| Manufacturing Standards | Establishes Current Good Manufacturing Practices (cGMP) |
| Labeling Requirements | Mandates specific information on prescription and OTC labels |
| Drug Recalls | Coordinates recall classifications (Class I, II, III) |
| Adverse Event Reporting | Manages MedWatch for reporting adverse drug reactions |
FDA Drug Recall Classifications
| Class | Severity | Example |
|---|---|---|
| Class I | Serious or life-threatening consequences | Contamination with lethal pathogen |
| Class II | Temporary or reversible health problems | Incorrect labeling of strength |
| Class III | Unlikely to cause adverse health consequences | Minor labeling errors |
National Drug Code (NDC)
The FDA assigns a unique 10-digit NDC number to each drug product.
NDC Format: XXXXX-XXXX-XX
- First segment (5 digits): Manufacturer/labeler
- Second segment (4 digits): Product code (drug, strength, dosage form)
- Third segment (2 digits): Package size
Example: 00002-3231-30 identifies a specific manufacturer, product, and package size
Poison Prevention Packaging Act (PPPA)
The Poison Prevention Packaging Act (1970) requires most prescription and OTC medications to be dispensed in child-resistant containers.
Requirements
- Packaging must be significantly difficult for children under 5 to open
- Must be tested and certified to meet opening standards
- Applies to most prescription drugs and many OTC products
Exceptions (Non-Child-Resistant Packaging Allowed)
| Situation | Example |
|---|---|
| Patient Request | Elderly or disabled patients who request easy-open caps |
| Prescriber Authorization | Written order for non-child-resistant packaging |
| Single-Use Packaging | Unit-dose or blister packs |
| Specific Drug Exemptions | Sublingual nitroglycerin, oral contraceptives in manufacturer packaging |
Documentation
When non-child-resistant containers are dispensed:
- Patient request must be documented
- Some pharmacies use blanket waivers; others document each instance
- Patient assumes responsibility for safe storage
OBRA-90 - Omnibus Budget Reconciliation Act
OBRA-90 (1990) established requirements for pharmacies serving Medicaid patients, though most pharmacies apply these standards to all patients.
Key OBRA-90 Requirements
| Requirement | Description |
|---|---|
| Prospective Drug Utilization Review (DUR) | Review each prescription for potential problems before dispensing |
| Patient Counseling Offer | Pharmacist must offer to counsel patients on new prescriptions |
| Patient Profiles | Maintain records of patient medications, allergies, conditions |
| Documentation | Record DUR interventions and counseling offers |
Prospective Drug Utilization Review
Pharmacists must review prescriptions for:
- Therapeutic duplication - Two drugs that do the same thing
- Drug-drug interactions - Dangerous combinations
- Incorrect dosage - Too high or too low
- Drug-disease contraindications - Medications inappropriate for patient conditions
- Drug-allergy interactions - Known patient allergies
- Clinical abuse/misuse - Patterns suggesting inappropriate use
Role of Pharmacy Technicians in OBRA-90 Compliance
While technicians cannot perform DUR or counseling, they support compliance by:
- Accurately entering patient information (allergies, conditions, other medications)
- Flagging potential issues for pharmacist review
- Documenting offers of counseling (per pharmacy policy)
- Maintaining accurate patient profiles
Combat Methamphetamine Epidemic Act (CMEA)
The CMEA (2005) restricts the sale of products containing pseudoephedrine, ephedrine, and phenylpropanolamine due to their use in methamphetamine production.
CMEA Requirements
| Requirement | Details |
|---|---|
| Behind the Counter | Products must be kept behind the counter or in a locked cabinet |
| Purchase Limits | 3.6 grams per day; 9 grams per 30-day period (mail-order: 7.5g/30 days) |
| ID Requirement | Valid photo ID required for purchase |
| Logbook | Record name, address, date/time, product, and quantity sold |
| Signature | Purchaser must sign the logbook |
| Record Retention | Logs must be kept for at least 2 years |
State Variations
Some states have additional restrictions:
- Prescription-only requirements (Oregon, Mississippi)
- Electronic tracking systems (NPLEx)
- Lower quantity limits
Other Important Federal Laws
Drug Supply Chain Security Act (DSCSA)
- Establishes requirements for tracking pharmaceutical products through the supply chain
- Requires transaction information, history, and statements (T3)
- Working toward full interoperable electronic tracing by 2023+
Isotretinoin Safety (iPLEDGE Program)
- FDA-mandated risk management program
- Requires registration of prescribers, pharmacies, and patients
- Monthly pregnancy tests for females of childbearing potential
- 7-day dispensing window after pregnancy test
Key Takeaways
- HIPAA protects patient health information (PHI) and requires privacy safeguards.
- The FDA regulates drug safety, efficacy, manufacturing, and labeling.
- The Poison Prevention Packaging Act requires child-resistant containers for most medications.
- The Omnibus Budget Reconciliation Act (OBRA-90) mandates prospective drug utilization review.
- The Combat Methamphetamine Epidemic Act restricts pseudoephedrine sales.
Under HIPAA, which of the following is considered Protected Health Information (PHI)?
A patient requests a non-child-resistant container for their medication. The pharmacy technician should:
The Combat Methamphetamine Epidemic Act limits pseudoephedrine purchases to: